Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
Year: 1993
Type: article
Source: PubMed
Authors: K D Chavin, L Qin, J Lin, A J Kaplan, J S Bromberg
Institution: Medical University of South Carolina
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2472572680
